Table: begin end state 1 20 cytoplasmic 21 42 transmembrane 43 50 non-cytoplasmic 51 74 transmembrane 75 94 cytoplasmic 95 119 transmembrane 120 130 non-cytoplasmic 131 153 transmembrane 154 162 cytoplasmic 163 185 transmembrane 186 204 non-cytoplasmic 205 227 transmembrane 228 247 cytoplasmic 248 266 transmembrane 267 292 non-cytoplasmic 293 313 transmembrane 314 338 cytoplasmic 339 359 transmembrane 360 364 non-cytoplasmic 365 390 transmembrane 391 410 cytoplasmic 411 431 transmembrane 432 436 non-cytoplasmic 437 455 transmembrane 456 476 cytoplasmic
Input: >Pf6N2E2_4959 MSIKEQQLNTRAGFKQEMQTRHIVMLALGGVIGTGLFLTSGYTVNQAGPMGAVIAYIIGA LMVYMVMMCLGELAVQMPETGSFSTYATRFLGPGTGYTVAWLYWLTWTVAIGSEFTAAGI LMSRWFPDTPVWIWSALFAGVVFLSNVISVRLFAETEFWLSLIKVLTVVVFLLIGGGAIL GLLNIDQAHSIGLSNFTREGLFPTGFMPIAMTLLAVSFAFSGTELIGIAAGETKDPQRNV PRAIRTTVLRLAVFFVGTIFVLATLLPREQAGLVESPFVTVFTYIGIPYSADIMNFVIIS ALLSAANSGLYAASRMLWTLSDQGHLPKQFSALTRMGTPLNAIIVSMAGGAASLLSSVFA ADTIYLALVSISGLAVVVVWMSIAASQIAFRRHYVANGGDIRKLKFRVRGYPWVPLGALV CCSLACIGIAFDPEQRVALYFGLPFIAWCYFVYYITRKSRERRLSVAFVAQPSDAF
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server